AI assistant could help primary care doctors think like specialists

NCT ID NCT07706920

Not yet recruiting Knowledge-focused Sponsor: Stanford University Source: ClinicalTrials.gov ↗

First seen Jul 16, 2026 · Last updated Jul 17, 2026 · Updated 1 time

Summary

This study tests an artificial intelligence tool called SAGE that helps primary care doctors make decisions about cases that might need a specialist. Doctors review made-up patient cases and make management decisions either with or without SAGE's recommendations. The goal is to see if SAGE helps doctors make sound, timely decisions that match what a specialist would advise.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance: SAGE, an artificial intelligence (AI) based clinical decision support tool that generates specialty-informed recommendations for primary care consultation questions
What this could lead to: If successful, SAGE could help primary care doctors make faster, more accurate decisions without needing a specialist, potentially reducing wait times and improving patient care.
What could go wrong: This is a small, early study with only 15 doctors using made-up cases, so real-world results may differ. The AI may not always match specialist advice or work well in all situations.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for DECISION SUPPORT SYSTEMS, CLINICAL are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

DECISION SUPPORT SYSTEMS, CLINICAL REFERRAL AND CONSULTATION

Contacts and locations

Show contact details

Locations

Stanford University

Stanford, California, 94305, United States

Contact Phone: •••-•••-•••• Email: •••••@•••••

More trials for these conditions

Other studies related to the condition(s) this trial covers.